MedPath
HSA Approval

DIMENHYDRINATE TABLETS 50 mg

SIN02765P

DIMENHYDRINATE TABLETS 50 mg

DIMENHYDRINATE TABLETS 50 mg

May 9, 1989

BEACONS PHARMACEUTICALS PTE. LTD.

BEACONS PHARMACEUTICALS PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantBEACONS PHARMACEUTICALS PTE. LTD.
Licence HolderBEACONS PHARMACEUTICALS PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Pharmacy Only
HSA Singapore Classification

Formulation Information

TABLET

ORAL

Medical Information

R06AA02

diphenhydramine

Manufacturer Information

BEACONS PHARMACEUTICALS PTE. LTD.

BEACONS PHARMACEUTICALS PTE. LTD.

Active Ingredients

DIMENHYDRINATE

50 mg

Dimenhydrinate

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

DIMENHYDRINATE TABLETS 50 mg - HSA Approval | MedPath